Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
drugs
3
×
life sciences
3
×
national blog main
new york blog main
san diego blog main
san diego top stories
biotech
boston blog main
boston top stories
fda
national top stories
new york top stories
achaogen
adams street partners
akcea therapeutics
alder biopharmaceutical
allergan
american academy of neurology
amgen
antibiotics
anylam pharmaceuticals
atogepant
beta lactamase inhibitor
biohaven
biomedical advanced research and development authority (barda)
bob azelby
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
calcitonin gene-related peptide
cardiomyopathy
deals
detroit blog main
detroit top stories
drug resistance
eli lilly
eptinezumab
erenumab
What
drug
year
3
×
disease
fda
medicines
ago
akcea
alnylam
amyloidosis
approval
approved
arguments
attr
available
bacteria
battle
big
biopharma
business
class
commercialized
companies
company
competitors
debilitating
decades
drugs
exited
fighting
genetic
infections
infectious
launches
make
meeting
melinta
migraine
neuro
new
oks
Language
Current search:
year
×
drugs
×
" life sciences "
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections